Icosavax(ICVX)
Search documents
Icosavax(ICVX) - 2023 Q3 - Quarterly Report
2023-11-14 22:21
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________to_________. Commission File Number: 001-40655 ICOSAVAX, INC. (Exact name of Registrant as specified in its charter) Delaware 82-3640549 (State or other juri ...
Icosavax(ICVX) - 2023 Q2 - Quarterly Report
2023-08-14 20:20
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________to_________. Commission File Number: 001-40655 ICOSAVAX, INC. (Exact name of Registrant as specified in its charter) Delaware 82-3640549 (State or other jurisdict ...
Icosavax(ICVX) - 2023 Q1 - Quarterly Report
2023-05-10 20:38
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________to_________. Commission File Number: 001-40655 ICOSAVAX, INC. (Exact name of Registrant as specified in its charter) Delaware 82-3640549 (State or other jurisdicti ...
Icosavax(ICVX) - 2022 Q4 - Annual Report
2023-03-30 20:36
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________to_________. Commission File Number: 001-40655 ICOSAVAX, INC. (Exact name of Registrant as specified in its charter) Delaware 82-3640549 (State or other jurisdiction of ...
Icosavax(ICVX) - 2022 Q2 - Quarterly Report
2022-08-15 21:33
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________to_________. Commission File Number: 001-40655 ICOSAVAX, INC. (Exact name of Registrant as specified in its charter) Delaware 82-3640549 (State or other jurisdictio ...
Icosavax(ICVX) - 2022 Q1 - Quarterly Report
2022-05-16 20:44
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________to_________. Commission File Number: 001-40655 ICOSAVAX, INC. (Exact name of Registrant as specified in its charter) Delaware 82-3640549 (State or other jurisdicti ...
Icosavax(ICVX) - 2021 Q4 - Annual Report
2022-03-30 21:03
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________to_________. Commission File Number: 001-40655 ICOSAVAX, INC. (Exact name of Registrant as specified in its charter) Delaware 82-3640549 (State or other jurisdiction of ...
Icosavax(ICVX) - 2021 Q3 - Quarterly Report
2021-11-15 21:35
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________to_________. Commission File Number: 001-40655 ICOSAVAX, INC. (Exact name of Registrant as specified in its charter) Delaware 82-3640549 (State or other jurisd ...
Icosavax(ICVX) - 2021 Q2 - Quarterly Report
2021-09-13 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________to_________. Commission File Number: 001-40655 ICOSAVAX, INC. (Exact name of Registrant as specified in its charter) Delaware 82-3640549 (State or other jurisdictio ...